# Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome

> **NCT00464373** · PHASE3 · TERMINATED · sponsor: **Daniel Stephan Engeler** · enrollment: 11 (actual)

## Conditions studied

- Chronic Prostatitis With Chronic Pelvic Pain Syndrome
- Prostatitis

## Interventions

- **DRUG:** Botulinum Toxin Type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00464373
- **Lead sponsor:** Daniel Stephan Engeler
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Slow accrual.
- **Last updated:** 2014-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464373, "Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00464373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*